213 related articles for article (PubMed ID: 30510401)
1. A new strategy for taste masking of azithromycin antibiotic: development, characterization, and evaluation of azithromycin titanium nanohybrid for masking of bitter taste using physisorption and panel testing studies.
Amin F; Khan S; Shah SMH; Rahim H; Hussain Z; Sohail M; Ullah R; Alsaid MS; Shahat AA
Drug Des Devel Ther; 2018; 12():3855-3866. PubMed ID: 30510401
[TBL] [Abstract][Full Text] [Related]
2. Formulation and biopharmaceutical evaluation of bitter taste masking microparticles containing azithromycin loaded in dispersible tablets.
Tung NT; Tran CS; Nguyen TL; Hoang T; Trinh TD; Nguyen TN
Eur J Pharm Biopharm; 2018 May; 126():187-200. PubMed ID: 28359878
[TBL] [Abstract][Full Text] [Related]
3. Formulation and physicochemical characterization of azithromycin-loaded cubosomes.
Zaker H; Taymouri S; Mostafavi A
Res Pharm Sci; 2023 Feb; 18(1):49-58. PubMed ID: 36846738
[TBL] [Abstract][Full Text] [Related]
4. Solvent-free method for masking the bitter taste of azithromycin dihydrate using supercritical fluid technology.
Mashaqbeh H; Obaidat RM; Alsmadi MM
Drug Dev Ind Pharm; 2024 Feb; 50(2):102-111. PubMed ID: 38180038
[TBL] [Abstract][Full Text] [Related]
5. Formulation design and pharmaceutical development of a novel controlled release form of azithromycin for single-dose therapy.
Lo JB; Appel LE; Herbig SM; McCray SB; Thombre AG
Drug Dev Ind Pharm; 2009 Dec; 35(12):1522-9. PubMed ID: 19929212
[TBL] [Abstract][Full Text] [Related]
6. Nanosponge-based pediatric-controlled release dry suspension of Gabapentin for reconstitution.
Rao MR; Bhingole RC
Drug Dev Ind Pharm; 2015; 41(12):2029-36. PubMed ID: 26006328
[TBL] [Abstract][Full Text] [Related]
7. HME-assisted formulation of taste-masked dispersible tablets of cefpodoxime proxetil and roxithromycin.
Patil PS; Suryawanshi SJ; Patil SS; Pawar AP
J Taibah Univ Med Sci; 2024 Apr; 19(2):252-262. PubMed ID: 38616800
[TBL] [Abstract][Full Text] [Related]
8. Tannate complexes of antihistaminic drug: sustained release and taste masking approaches.
Rahman Z; Zidan AS; Berendt RT; Khan MA
Int J Pharm; 2012 Jan; 422(1-2):91-100. PubMed ID: 22037447
[TBL] [Abstract][Full Text] [Related]
9. Palatable reconstitutable dry suspension of artemether for flexible pediatric dosing using cyclodextrin inclusion complexation.
Shah PP; Mashru RC
Pharm Dev Technol; 2010 Jun; 15(3):276-85. PubMed ID: 22716468
[TBL] [Abstract][Full Text] [Related]
10. Mesoporous Silica Carrier-Based Composites for Taste-Masking of Bitter Drug: Fabrication and Palatability Evaluation.
Zhang W; Li G; Xiao C; Chang X; Sun Y; Fan W; Tian B; Gao D; Xiao Y; Wu X; He S; Zhai G
AAPS PharmSciTech; 2022 Feb; 23(2):75. PubMed ID: 35169970
[TBL] [Abstract][Full Text] [Related]
11. Preparation of polymer-blended quinine nanocomposite particles by spray drying and assessment of their instrumental bitterness-masking effect using a taste sensor.
Taki M; Tagami T; Ozeki T
Drug Dev Ind Pharm; 2017 May; 43(5):715-722. PubMed ID: 27401130
[TBL] [Abstract][Full Text] [Related]
12. Human volunteer, in vitro, and molecular level evaluation of an optimized taste-masked isoniazid-chitosan spray-dried microparticle matrix.
Stagner WC; Iyer M; Rathod V; Meruva S; Staton S; Haware RV
Int J Pharm; 2019 Dec; 572():118774. PubMed ID: 31678392
[TBL] [Abstract][Full Text] [Related]
13. Formulation and evaluation of taste masked oral reconstitutable suspension of primaquine phosphate.
Shah PP; Mashru RC
AAPS PharmSciTech; 2008; 9(3):1025-30. PubMed ID: 18770047
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of artemether taste masked rapid disintegrating tablets with improved dissolution using solid dispersion technique.
Shah PP; Mashru RC
AAPS PharmSciTech; 2008; 9(2):494-500. PubMed ID: 18431657
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.
Drašković M; Medarević D; Aleksić I; Parojčić J
Drug Dev Ind Pharm; 2017 May; 43(5):723-731. PubMed ID: 27494420
[TBL] [Abstract][Full Text] [Related]
16. Fabrication and characterization of a titanium dioxide (TiO
Ahmadi R; Tanomand A; Kazeminava F; Kamounah FS; Ayaseh A; Ganbarov K; Yousefi M; Katourani A; Yousefi B; Kafil HS
Int J Nanomedicine; 2019; 14():3439-3454. PubMed ID: 31190802
[No Abstract] [Full Text] [Related]
17. Dry Suspension Containing Coated Pellets with pH-Dependent Drug Release Behavior for the Taste-masking of Azithromycin.
Chen Y; Liu Y; Wu C; Pan X; Peng T
AAPS PharmSciTech; 2022 Dec; 24(1):21. PubMed ID: 36526883
[TBL] [Abstract][Full Text] [Related]
18. Application of salt engineering to reduce/mask bitter taste of clindamycin.
Barakh Ali SF; Dharani S; Afrooz H; Khan MA; Mohamed EM; Kohli K; Rahman Z
Drug Dev Ind Pharm; 2019 Dec; 45(12):1871-1878. PubMed ID: 31549523
[TBL] [Abstract][Full Text] [Related]
19. Development and Evaluation of Taste Masked Granular Formulation of Satranidazole by Melt Granulation Technique.
Pawar HA; Joshi PR
J Pharm (Cairo); 2014; 2014():789676. PubMed ID: 26556200
[TBL] [Abstract][Full Text] [Related]
20. A Novel Method to Mask the Bitter Taste of Berberine Hydrochloride: Powder Surface Modification.
Jiang H; Zhang D; He J; Han X; Lin J; Lan Y; Xiong X; Yu L; Yang M; Han L
Pharmacogn Mag; 2018; 14(54):253-260. PubMed ID: 29720841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
